Dr. med. et phil. nat. David Semela
chief of service
Gastroenterology/Hepatology · Dept. I
Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
Terczyńska-Dyla E, Moradpour D, Mullhaupt B, Negro F, Santoro R, Semela D, Semmo N, Swiss Hepatitis C Cohort Study Group, Heim M, Bochud P, Mangia A, Malinverni R, Bibert S, Duong F, Krol I, Jørgensen S, Collinet E, Kutalik Z, Aubert V, Cerny A, Kaiser L, Hartmann R. Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes. Nat Commun 2015; 6:7280.
Jun 29, 2015Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
Jun 29, 2015Nat Commun 2015; 6:7280
Terczyńska-Dyla Ewa, Moradpour Darius, Mullhaupt Beat, Negro Francesco, Santoro Rosanna, Semela David, Semmo Nasser, Swiss Hepatitis C Cohort Study Group, Heim Markus H, Bochud Pierre-Yves, Mangia Alessandra, Malinverni Raffaele, Bibert Stéphanie, Duong Francois H T, Krol Ilona, Jørgensen Sanne, Collinet Emilie, Kutalik Zoltán, Aubert Vincent, Cerny Andreas, Kaiser Laurent, Hartmann Rune
Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland
Mullhaupt B, Bruggmann P, Bihl F, Blach S, Lavanchy D, Razavi H, Semela D, Negro F. Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland. PloS one 2015; 10:e0125214.
Jun 24, 2015Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland
Jun 24, 2015PloS one 2015; 10:e0125214
Mullhaupt Beat, Bruggmann Philip, Bihl Florian, Blach Sarah, Lavanchy Daniel, Razavi Homie, Semela David, Negro Francesco
Life-threatening bleeding from peristomal varices after cystoprostatectomy: multimodal approach in a cirrhotic, encephalopathic patient with severe portal hypertension
Staubli S, Gramann T, Schwab C, Semela D, Hechelhammer L, Engeler D, Schmid H, Abt D, Mordasini L. Life-threatening bleeding from peristomal varices after cystoprostatectomy: multimodal approach in a cirrhotic, encephalopathic patient with severe portal hypertension. Case Rep Urol 2015; 2015:785010.
Jan 29, 2015Life-threatening bleeding from peristomal varices after cystoprostatectomy: multimodal approach in a cirrhotic, encephalopathic patient with severe portal hypertension
Jan 29, 2015Case Rep Urol 2015; 2015:785010
Staubli Sergej, Gramann Tobias, Schwab Christoph, Semela David, Hechelhammer Lukas, Engeler Daniel, Schmid Hans-Peter, Abt Dominik, Mordasini Livio
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
Terczyńska-Dyla E, Moradpour D, Mullhaupt B, Negro F, Santoro R, Semela D, Semmo N, Swiss Hepatitis C Cohort Study Group, Heim M, Bochud P, Mangia A, Malinverni R, Bibert S, Duong F, Krol I, Jørgensen S, Collinet E, Kutalik Z, Aubert V, Cerny A, Kaiser L, Hartmann R. Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes. Nat Commun 2014; 5:5699.
Dec 23, 2014Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
Dec 23, 2014Nat Commun 2014; 5:5699
Terczyńska-Dyla Ewa, Moradpour Darius, Mullhaupt Beat, Negro Francesco, Santoro Rosanna, Semela David, Semmo Nasser, Swiss Hepatitis C Cohort Study Group, Heim Markus H, Bochud Pierre-Yves, Mangia Alessandra, Malinverni Raffaele, Bibert Stéphanie, Duong Francois H T, Krol Ilona, Jørgensen Sanne, Collinet Emilie, Kutalik Zoltán, Aubert Vincent, Cerny Andreas, Kaiser Laurent, Hartmann Rune
Generation of a murine hepatic angiosarcoma cell line and reproducible mouse tumor model
Rothweiler S, Dill M, Terracciano L, Makowska Z, Quagliata L, Hlushchuk R, Djonov V, Heim M, Semela D. Generation of a murine hepatic angiosarcoma cell line and reproducible mouse tumor model. Lab Invest 2014
Nov 24, 2014Generation of a murine hepatic angiosarcoma cell line and reproducible mouse tumor model
Nov 24, 2014Lab Invest 2014
Rothweiler Sonja, Dill Michael T, Terracciano Luigi, Makowska Zuzanna, Quagliata Luca, Hlushchuk Ruslan, Djonov Valentin, Heim Markus H, Semela David
Accuracy of contrast - enhanced ultrasound for tumor response after RFA / TACE in malignant focal liver lesions in comparison with CT / MRI in a tertiary Swiss GI center
Sawatzki M, Hechelhammer L, Semela D (2014). Accuracy of contrast - enhanced ultrasound for tumor response after RFA / TACE in malignant focal liver lesions in comparison with CT / MRI in a tertiary Swiss GI center.
Sep 20, 2014Accuracy of contrast - enhanced ultrasound for tumor response after RFA / TACE in malignant focal liver lesions in comparison with CT / MRI in a tertiary Swiss GI center
Sep 20, 2014SGG
Sawatzki Mikael, Hechelhammer Lukas, Semela David
"Fighting an uphill battle": experience with the HCV triple therapy: a qualitative thematic analysis
Rasi M, Künzler-Heule P, Schmid P, Semela D, Bruggmann P, Fehr J, Saxer S, Nicca D. "Fighting an uphill battle": experience with the HCV triple therapy: a qualitative thematic analysis. BMC Infect Dis 2014; 14:507.
Sep 18, 2014"Fighting an uphill battle": experience with the HCV triple therapy: a qualitative thematic analysis
Sep 18, 2014BMC Infect Dis 2014; 14:507
Rasi Manuela, Künzler-Heule Patrizia, Schmid Patrick, Semela David, Bruggmann Philip, Fehr Jan, Saxer Susi, Nicca Dunja
Impact of common risk factors of fibrosis progression in chronic hepatitis C
Rüeger S, Halfon P, Bourlière M, Talal A, Jacobson I, Patin E, Nalpas B, Poynard T, Pol S, Abel L, Kutalik Z, Argiro L, George J, Bochud P, Dufour J, Mullhaupt B, Semela D, Heim M, Moradpour D, Cerny A, Malinverni R, Booth D, Suppiah V, Negro F. Impact of common risk factors of fibrosis progression in chronic hepatitis C. Gut 2014
Sep 11, 2014Impact of common risk factors of fibrosis progression in chronic hepatitis C
Sep 11, 2014Gut 2014
Rüeger S, Halfon P, Bourlière M, Talal A H, Jacobson I M, Patin E, Nalpas B, Poynard T, Pol S, Abel L, Kutalik Z, Argiro L, George J, Bochud P-Y, Dufour J-F, Mullhaupt B, Semela David, Heim M H, Moradpour D, Cerny A, Malinverni R, Booth D R, Suppiah V, Negro F
Clinical significance of the CCR5delta32 allele in hepatitis C
Morard I, Negro F, Bochud P, Pascarella S, Semela D, Mullhaupt B, Moradpour D, Malinverni R, Heim M, Gorgievski M, De Gottardi A, Cerny A, Mangia A, Calmy A, Clément S, Swiss Hepatitis C Cohort Study Group. Clinical significance of the CCR5delta32 allele in hepatitis C. PloS one 2014; 9:e106424.
Sep 5, 2014Clinical significance of the CCR5delta32 allele in hepatitis C
Sep 5, 2014PloS one 2014; 9:e106424
Morard Isabelle, Negro Franco, Bochud Pierre-Yves, Pascarella Stéphanie, Semela David, Mullhaupt Beat, Moradpour Darius, Malinverni Raffaele, Heim Markus, Gorgievski Meri, De Gottardi Andrea, Cerny Andrea, Mangia Alessandra, Calmy Alexandra, Clément Sophie, Swiss Hepatitis C Cohort Study Group
Strategies to manage hepatitis C virus (HCV) disease burden
Kautz A, Myers R, Nemecek V, Øvrehus A, Parkes J, Peltekian K, Ramji A, Razavi H, Reis N, Roberts S, Mullhaupt B, Moreno C, Mendes Correa M, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marinho R, Marotta P, Mauss S, Roudot-Thoraval F, Ryder S, Vandijck D, Vogel W, Waked I, Weis N, Wiegand J, Yosry A, Zekry A, Negro F, Sievert W, van Thiel I, Van Damme P, Urbanek P, Sarmento-Castro R, Sarrazin C, Semela D, Sherman M, Shiha G, Sperl J, Stärkel P, Stauber R, Thompson A, Gower E, Kaita K, Wedemeyer H, Bihl F, Bilodeau M, Blasco A, Brandão Mello C, Bruggmann P, Calinas F, Calleja J, Cheinquer H, Christensen P, Berg T, Balık I, Aleman S, Duberg A, Buti M, Rosenberg W, Frankova S, Esmat G, Örmeci N, Van Vlierberghe H, Gschwantler M, Akarca U, Clausen M, Coelho H, Gerstoft J, Giria J, Gonçales F, Guimarães Pessôa M, Hézode C, Hindman S, Hofer H, Husa P, Idilman R, García-Samaniego J, Ferreira P, Ferraz M, Cornberg M, Cramp M, Dore G, Doss W, El-Sayed M, Ergör G, Estes C, Falconer K, Félix J, Kåberg M. Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat 2014; 21 Suppl 1:60-89.
May 1, 2014Strategies to manage hepatitis C virus (HCV) disease burden
May 1, 2014J Viral Hepat 2014; 21 Suppl 1:60-89
Kautz A, Myers R P, Nemecek V, Øvrehus A L H, Parkes J, Peltekian K M, Ramji A, Razavi H, Reis N, Roberts S K, Mullhaupt B, Moreno C, Mendes Correa M C, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marinho R T, Marotta P, Mauss S, Roudot-Thoraval F, Ryder S D, Vandijck D, Vogel W, Waked I, Weis N, Wiegand J, Yosry A, Zekry A, Negro F, Sievert W, van Thiel I, Van Damme P, Urbanek P, Sarmento-Castro R, Sarrazin C, Semela David, Sherman M, Shiha G E, Sperl J, Stärkel P, Stauber R E, Thompson A J, Gower E, Kaita K D E, Wedemeyer H, Bihl F, Bilodeau M, Blasco A J, Brandão Mello C E, Bruggmann P, Calinas F, Calleja J L, Cheinquer H, Christensen P B, Berg T, Balık I, Aleman S, Duberg A S, Buti M, Rosenberg W M, Frankova S, Esmat G, Örmeci N, Van Vlierberghe H, Gschwantler M, Akarca U, Clausen M, Coelho H S M, Gerstoft J, Giria J A, Gonçales F L, Guimarães Pessôa M, Hézode C, Hindman S J, Hofer H, Husa P, Idilman R, García-Samaniego J, Ferreira P R, Ferraz M L G, Cornberg M, Cramp M E, Dore G J, Doss W, El-Sayed M H, Ergör G, Estes C, Falconer K, Félix J, Kåberg M
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
Kaita K, Nemecek V, Örmeci N, Øvrehus A, Parkes J, Pasini K, Peltekian K, Ramji A, Reis N, Roberts S, Negro F, Murphy K, Moreno C, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Marinho R, Marotta P, Mauss S, Rosenberg W, Roudot-Thoraval F, Ryder S, Van Vlierberghe H, Vandijck D, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Cornberg M, Mullhaupt B, van Thiel I, Van Damme P, Urbanek P, Sarmento-Castro R, Semela D, Sherman M, Shiha G, Sievert W, Sperl J, Stärkel P, Stauber R, Thompson A, Estes C, Kåberg M, Razavi H, Berg T, Bihl F, Bilodeau M, Blasco A, Brandão Mello C, Bruggmann P, Buti M, Calleja J, Cheinquer H, Balık I, Aleman S, Akarca U, Waked I, Sarrazin C, Myers R, Idilman R, Calinas F, Vogel W, Mendes Correa M, Hézode C, Lázaro P, Christensen P, Clausen M, Coelho H, García-Samaniego J, Gerstoft J, Giria J, Gonçales F, Gower E, Gschwantler M, Guimarães Pessôa M, Hindman S, Hofer H, Frankova S, Ferreira P, Ferraz M, Cramp M, Dore G, Doss W, Duberg A, El-Sayed M, Ergör G, Esmat G, Falconer K, Félix J, Husa P. The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat 2014; 21 Suppl 1:34-59.
May 1, 2014The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
May 1, 2014J Viral Hepat 2014; 21 Suppl 1:34-59
Kaita K D E, Nemecek V, Örmeci N, Øvrehus A L H, Parkes J, Pasini K, Peltekian K M, Ramji A, Reis N, Roberts S K, Negro F, Murphy K, Moreno C, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Marinho R T, Marotta P, Mauss S, Rosenberg W M, Roudot-Thoraval F, Ryder S D, Van Vlierberghe H, Vandijck D, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Cornberg M, Mullhaupt B, van Thiel I, Van Damme P, Urbanek P, Sarmento-Castro R, Semela David, Sherman M, Shiha G E, Sievert W, Sperl J, Stärkel P, Stauber R E, Thompson A J, Estes C, Kåberg M, Razavi H, Berg T, Bihl F, Bilodeau M, Blasco A J, Brandão Mello C E, Bruggmann P, Buti M, Calleja J L, Cheinquer H, Balık I, Aleman S, Akarca U, Waked I, Sarrazin C, Myers R P, Idilman R, Calinas F, Vogel W, Mendes Correa M C, Hézode C, Lázaro P, Christensen P B, Clausen M, Coelho H S M, García-Samaniego J, Gerstoft J, Giria J A, Gonçales F L, Gower E, Gschwantler M, Guimarães Pessôa M, Hindman S J, Hofer H, Frankova S, Ferreira P R, Ferraz M L G, Cramp M E, Dore G J, Doss W, Duberg A S, El-Sayed M H, Ergör G, Esmat G, Falconer K, Félix J, Husa P
Historical epidemiology of hepatitis C virus (HCV) in selected countries
Kåberg M, Myers R, Negro F, Nemecek V, Örmeci N, Parkes J, Peltekian K, Ramji A, Razavi H, Reis N, Mullhaupt B, Mendes Correa M, Mauss S, Kaita K, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marotta P, Roberts S, Rosenberg W, Vogel W, Waked I, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Van Damme P, Aleman S, Vandijck D, Van Vlierberghe H, van Thiel I, Sarmento-Castro R, Sarrazin C, Semela D, Shiha G, Sievert W, Stärkel P, Stauber R, Thompson A, Urbanek P, Hindman S, Idilman R, Bruggmann P, Bilodeau M, Blasco A, Buti M, Calinas F, Calleja J, Cheinquer H, Christensen P, Clausen M, Coelho H, Bihl F, Balık I, Akarca U, Berg T, Øvrehus A, Moreno C, Brandão Mello C, Roudot-Thoraval F, Marinho R, Sherman M, Ryder S, Sperl J, Cornberg M, Cramp M, García-Samaniego J, Gerstoft J, Giria J, Gonçales F, Gower E, Gschwantler M, Guimarães Pessôa M, Hézode C, Hofer H, Frankova S, Ferreira P, Ferraz M, Dore G, Doss W, Duberg A, El-Sayed M, Ergör G, Esmat G, Estes C, Falconer K, Félix J, Husa P. Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat 2014; 21 Suppl 1:5-33.
May 1, 2014Historical epidemiology of hepatitis C virus (HCV) in selected countries
May 1, 2014J Viral Hepat 2014; 21 Suppl 1:5-33
Kåberg M, Myers R P, Negro F, Nemecek V, Örmeci N, Parkes J, Peltekian K M, Ramji A, Razavi H, Reis N, Mullhaupt B, Mendes Correa M C, Mauss S, Kaita K D E, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marotta P, Roberts S K, Rosenberg W M, Vogel W, Waked I, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Van Damme P, Aleman S, Vandijck D, Van Vlierberghe H, van Thiel I, Sarmento-Castro R, Sarrazin C, Semela David, Shiha G E, Sievert W, Stärkel P, Stauber R E, Thompson A J, Urbanek P, Hindman S J, Idilman R, Bruggmann P, Bilodeau M, Blasco A J, Buti M, Calinas F, Calleja J L, Cheinquer H, Christensen P B, Clausen M, Coelho H S M, Bihl F, Balık I, Akarca U, Berg T, Øvrehus A L H, Moreno C, Brandão Mello C E, Roudot-Thoraval F, Marinho R T, Sherman M, Ryder S D, Sperl J, Cornberg M, Cramp M E, García-Samaniego J, Gerstoft J, Giria J A, Gonçales F L, Gower E, Gschwantler M, Guimarães Pessôa M, Hézode C, Hofer H, Frankova S, Ferreira P R, Ferraz M L G, Dore G J, Doss W, Duberg A S, El-Sayed M H, Ergör G, Esmat G, Estes C, Falconer K, Félix J, Husa P
[Malignant hypoglycaemia]
Rigger J, Kleger G, Semela D, Doenecke C, Rodriguez R, Meyenberger C, Köberle D, Sawatzki M. [Malignant hypoglycaemia]. Praxis (Bern 1994) 2014; 103:399-403.
Mar 26, 2014[Malignant hypoglycaemia]
Mar 26, 2014Praxis (Bern 1994) 2014; 103:399-403
Rigger Johannes, Kleger Gian-Reto, Semela David, Doenecke Christian, Rodriguez Regulo, Meyenberger Christa, Köberle Dieter, Sawatzki Mikael
Maligne Hypoglykämie
Rigger J, Kleger G, Semela D, Doenecke C, Rodriguez R, Meyenberger C, Köberle D, Sawatzki M. Maligne Hypoglykämie. Praxis 2014; 103 (7):399-403.
Feb 1, 2014Maligne Hypoglykämie
Feb 1, 2014Praxis 2014; 103 (7):399-403
Rigger Johannes, Kleger Gian Reto, Semela David, Doenecke Christian, Rodriguez Regulo, Meyenberger Christa, Köberle Dieter, Sawatzki Mikael
Nodular regenerative hyperplasia in a patient with generalized essential telangiectasia: Endotheliopathy as causal factor
Rothweiler S, Heim M, Semela D. Nodular regenerative hyperplasia in a patient with generalized essential telangiectasia: Endotheliopathy as causal factor. Hepatology 2013
Nov 22, 2013Nodular regenerative hyperplasia in a patient with generalized essential telangiectasia: Endotheliopathy as causal factor
Nov 22, 2013Hepatology 2013
Rothweiler Sonja, Heim Markus H, Semela David
Inhibition of Notch signaling induces extensive intussusceptive neo-angiogenesis by recruitment of mononuclear cells
Dimova I, Chatterjee S, Le Noble F, Semela D, Lang S, Flueckiger S, Ceausu A, Styp-Rekowska B, Makanya A, Hlushchuk R, Djonov V. Inhibition of Notch signaling induces extensive intussusceptive neo-angiogenesis by recruitment of mononuclear cells. Angiogenesis 2013; 16:921-37.
Jul 24, 2013Inhibition of Notch signaling induces extensive intussusceptive neo-angiogenesis by recruitment of mononuclear cells
Jul 24, 2013Angiogenesis 2013; 16:921-37
Dimova Ivanka, Chatterjee Suvro, Le Noble Ferdinand, Semela David, Lang Sonja, Flueckiger Stefanie, Ceausu Amalia, Styp-Rekowska Beata, Makanya Andrew, Hlushchuk Ruslan, Djonov Valentin
Downregulation of the Endothelial Genes Notch1 and EphrinB2 in Patients with Nodular Regenerative Hyperplasia
Rothweiler S, Terracciano L, Tornillo L, Dill M, Heim M, Semela D. Downregulation of the Endothelial Genes Notch1 and EphrinB2 in Patients with Nodular Regenerative Hyperplasia. Liver Int 2013
Jun 23, 2013Downregulation of the Endothelial Genes Notch1 and EphrinB2 in Patients with Nodular Regenerative Hyperplasia
Jun 23, 2013Liver Int 2013
Rothweiler Sonja, Terracciano Luigi, Tornillo Luigi, Dill Michael T, Heim Markus H, Semela David
Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development
Lange C, Negro F, Semela D, Kutalik Z, Müller T, Spengler U, Berg T, Chayama K, Moradpour D, Bochud P, Hiroshima Liver Study Group, Mullhaupt B, Malinverni R, Heim M, Miki D, Ochi H, Nischalke H, Bojunga J, Bibert S, Morikawa K, Gouttenoire J, Cerny A, Dufour J, Gorgievski-Hrisoho M, Swiss Hepatitis C Cohort Study Group. Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development. PloS one 2013; 8:e64053.
May 29, 2013Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development
May 29, 2013PloS one 2013; 8:e64053
Lange Christian M, Negro Francesco, Semela David, Kutalik Zoltán, Müller Tobias, Spengler Ulrich, Berg Thomas, Chayama Kazuaki, Moradpour Darius, Bochud Pierre-Yves, Hiroshima Liver Study Group, Mullhaupt Beat, Malinverni Raffaele, Heim Markus H, Miki Daiki, Ochi Hidenori, Nischalke Hans-Dieter, Bojunga Jörg, Bibert Stéphanie, Morikawa Kenichi, Gouttenoire Jérôme, Cerny Andreas, Dufour Jean-François, Gorgievski-Hrisoho Meri, Swiss Hepatitis C Cohort Study Group
[Non-cirrhotic portal hypertension with nearly lethal consequences]
Börner N, Korte W, Doenecke C, Pfister M, Meyenberger C, Semela D, Sawatzki M. [Non-cirrhotic portal hypertension with nearly lethal consequences]. Praxis (Bern 1994) 2013; 102:681-5.
May 22, 2013[Non-cirrhotic portal hypertension with nearly lethal consequences]
May 22, 2013Praxis (Bern 1994) 2013; 102:681-5
Börner Nele, Korte Wolfgang, Doenecke Christian, Pfister Maurus, Meyenberger Christa, Semela David, Sawatzki Mikael
Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma
Lange C, Bochud P, Kutalik Z, Moradpour D, Semela D, Negro F, Mullhaupt B, Malinverni R, Kaiser L, Heim M, Cerny A, Cellerai C, Dufour J, Bibert S, Swiss Hepatitis C Cohort Study Group. Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma. J Hepatol 2013; 59:504-9.
May 9, 2013Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma
May 9, 2013J Hepatol 2013; 59:504-9
Lange Christian M, Bochud Pierre-Yves, Kutalik Zoltán, Moradpour Darius, Semela David, Negro Francesco, Mullhaupt Beat, Malinverni Raffaele, Kaiser Laurent, Heim Markus H, Cerny Andreas, Cellerai Cristina, Dufour Jean-François, Bibert Stéphanie, Swiss Hepatitis C Cohort Study Group